Brustkrebs in der letzten Lebensphase: Stellenwert der palliativen Strahlentherapie

Die palliative Strahlentherapie stellt eine der effektivsten Maßnahmen zur Reduktion von Schmerzen bei metastasierten Brustkrebspatientinnen dar. Insbesondere in der letzten Lebensphase kann die Indikationsstellung und die Auswahl des optimalen Therapiekonzeptes jedoch eine Herausforderung darstellen.

• Literatur

• 1 von Moos R, Costa L, Ripamonti CI. et al. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. Eur J Cancer 2017; 71: 80-94
• 2 Sierko E, Hempel D, Zuzda K. et al. Personalized Radiation Therapy in Cancer Pain Management. Cancers (Basel) 2019; 11: 390
• 3 Spencer K, Parrish R, Barton R. et al. Palliative radiotherapy. BMJ 2018; 360: k821
• 4 Chow E, Meyer RM, Ding K. et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol 2015; 16: 1463-1472
• 5 Chow R, Hoskin P, Chan S. et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol 2017; 122: 323-331
• 6 Chow E, Zeng L, Salvo N. et al. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 2012; 24: 112-124
• 7 Koswig S, Buchali A, Böhmer D. et al. Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients. Strahlenther Onkol 1999; 175: 509-514
• 8 Sahgal A, Myrehaug SD, Siva S. et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol 2021; 22: 1023-1033
• 9 Wu SY, Singer L, Boreta L. et al. Palliative radiotherapy near the end of life. BMC Palliat Care 2019; 18: 29
• 10 McDonald R, Ding K, Brundage M. et al. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23. JAMA Oncol 2017; 3: 953-959
• 11 Dennis K, Wong K, Zhang L. et al. Palliative radiotherapy for bone metastases in the last 3 months of life: worthwhile or futile?. Clin Oncol (R Coll Radiol) 2011; 23: 709-715
• 12 Miyashita M, Yasuda M, Baba R. et al. Inter-rater reliability of proxy simple symptom assessment scale between physician and nurse: a hospital-based palliative care team setting. Eur J Cancer Care (Engl) 2010; 19: 124-130